Search for: "United States v. Lowe's Inc"
Results 781 - 800
of 1,150
Sort by Relevance
|
Sort by Date
8 Jan 2012, 12:56 pm
” Paramount Communications Inc. v. [read post]
7 Jan 2012, 7:48 am
This has significant effects upon the United States. . . . [read post]
3 Jan 2012, 2:19 pm
Montana’s high court, with two members dissenting in Western Tradition Partnership, Inc. v. [read post]
30 Dec 2011, 5:17 pm
(Eugene Volokh) In today’s Western Tradition Partnership, Inc. v. [read post]
28 Dec 2011, 5:29 pm
For example, in Tele-Pac, Inc. v. [read post]
27 Dec 2011, 9:56 am
Janssen Pharmaceuticals, Inc., 951 N.E.2d 1238 (Ill. [read post]
27 Dec 2011, 7:18 am
Bel Canto Design, Ltd. v. [read post]
22 Dec 2011, 11:59 am
Wyeth Pharmaceuticals, Inc., 15 A.3d 909 (Pa. [read post]
15 Dec 2011, 6:25 am
Dukes and AT&T Mobility v. [read post]
14 Dec 2011, 10:59 am
Note that United States v. [read post]
10 Dec 2011, 6:20 am
For the facts, see United States v. [read post]
7 Dec 2011, 6:21 pm
Government argued as amicus curiae for the perspective of the United States and the U.S. [read post]
2 Dec 2011, 5:01 am
United Services Auto. [read post]
1 Dec 2011, 10:10 pm
Inc. v. [read post]
28 Nov 2011, 4:02 am
Coming back to Propecia, the warning label in the United States didn’t mention until June of this year, but the warning labels in the United Kingdom have said for some time: In addition, the following have been reported in postmarketing use: persistence of erectile dysfunction after discontinuation of treatment with PROPECIA; male breast cancer (see 4.4 Special warnings and precautions for use) Propecia in Sweden and Italy has similar warnings. [read post]
14 Nov 2011, 7:50 am
As in the United States, pre-merger integration, coordination and/or information sharing is an important antitrust issue under Canada's Competition Act. [read post]
3 Nov 2011, 9:12 pm
Finally, recent United States Supreme Court cases Rent-A-Center, West, Inc. v. [read post]
31 Oct 2011, 6:46 pm
In Chappell v. [read post]
31 Oct 2011, 7:30 am
USPTO is IncompleteBy: Kristin Wall In March of 2010, the United States Court of Appeals for the Southern District of New York invalidated Myriad Genetics' patents on the BRCA1/2 genes, which predict susceptibility to breast and ovarian cancer. [read post]
31 Oct 2011, 5:14 am
Medtronic, Inc. v. [read post]
